Cite
HARVARD Citation
Narayan, H. et al. (2023). Cardiovascular toxicities with pediatric tyrosine kinase inhibitor therapy: An analysis of adverse events reported to the Food and Drug Administration. Pediatric blood & cancer. 70 (2), p. n/a. [Online].